PLAT and stroke disorder: In a study conducted by Pedersen et al., hsCRP was investigated along with fibrinogen and tissue plasminogen activator (tPA), which are involved in hemostasis and anti-coagulation, as a potential predictor for cognitive outcomes 7 years after stroke among young stroke patients < 50 years old.